Jaival Pharmaceuticals LLP

Jaival Pharmaceuticals LLP - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAW-7813 Incorporated 21 April 2021 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership chemicals
Data last updated
Contribution obligation
₹1.5 Lakh
As per LLP agreement
LLP age
5 yrs
Est. 2021
Designated partners
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Mumbai
ROC office
Incorporated
21 Apr 2021
Date of incorporation

About Jaival Pharmaceuticals LLP

Data last updated:

Jaival Pharmaceuticals LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 21 April 2021 and has been in existence for over 5 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAW-7813. Its GSTIN is 27AARFJ1523C1ZK (Maharashtra).

The LLP has a total obligation of contribution of ₹1.5 Lakh. It is led by designated partners Ekta Yogeshkumar Gulati and Jay Babu Athawale.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 487 Narayan Nagar Vacal Stock Yard Depot Ghatkopar West, Mumbai, Maharashtra, India – 400086.

Company Details of Jaival Pharmaceuticals LLP
LLPIN AAW-7813
Incorporation Date 21 April 2021
Total Obligation of Contribution ₹1.5 Lakh
ROC Mumbai
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Ekta Yogeshkumar Gulati Designated Partner Jay Babu Athawale Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    487 Narayan Nagar Vacal Stock Yard Depot Ghatkopar West, Mumbai, Maharashtra, India – 400086
  • Industry
    Chemicals, Chemicals and Chemical Products, Manufacturing
Comprehensive company report
Jaival Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Jaival Pharmaceuticals LLP report

Financials, compliance, directors, charges, ownership and filings for Jaival Pharmaceuticals LLP in one report.

Financials from FY 2022 Directors & ownership Charges & compliance

Financials of Jaival Pharmaceuticals LLP FY 2025 filings available

Financial Statement Summary of Jaival Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income and Expenditure
Turnover••••••••••••••••
Other Income••••••••••••••••
Total Income••••••••••••••••
Purchases and Direct Costs••••••••••••••••
Personnel Expenses••••••••••••••••
Administrative Expenses••••••••••••••••
Interest••••••••••••••••
Depreciation••••••••••••••••
Total Expenses••••••••••••••••
Profit Before Tax••••••••••••••••
Tax••••••••••••••••
Profit After Tax••••••••••••••••
Profit Transferred to Partners••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••
Reserves and Surplus••••••••••••••••
Secured Loans••••••••••••••••
Unsecured Loans••••••••••••••••
Trade Payables••••••••••••••••
Other Liabilities and Provisions••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Loans and Advances••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Jaival Pharmaceuticals LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
Net Profit Margin••••••••••••••••
Return on Partners' Funds••••••••••••••••
Return on Assets••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Debt to Partners' Funds••••••••••••••••
Interest Coverage••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Turnover Growth••••••••••••••••
Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Jaival Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2022

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Jaival Pharmaceuticals LLP

Jaival Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Ekta Yogeshkumar GulatiDesignated Partner21 Apr 20215 Years 5 MonthsCurrent
Jay Babu AthawaleDesignated Partner21 Apr 20215 Years 5 MonthsCurrent
View all designated partners

Charges & Borrowings of Jaival Pharmaceuticals LLP

Jaival Pharmaceuticals LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Jaival Pharmaceuticals LLP

Employment history and EPFO contributions of people linked to Jaival Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Jaival Pharmaceuticals LLP

Jaival Pharmaceuticals LLP has 2 designated partner changes on record since 2021: 2 appointments. The latest: Ekta Yogeshkumar Gulati was appointed as Designated Partner on 21 Apr 2021.

AGM
Jaival Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Jaival Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Ekta Yogeshkumar Gulati was appointed as Designated Partner.
Appointed
Jay Babu Athawale was appointed as Designated Partner.
Incorporation
21 Apr 2021
Jaival Pharmaceuticals Llp was registered on 21 Apr 2021 with Roc Mumbai & aged 5 years 5 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Jaival Pharmaceuticals LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Jaival Pharmaceuticals LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Jaival Pharmaceuticals LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Jaival Pharmaceuticals LLP

Jaival Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AARFJ1523C1ZKMaharashtraActive11 Jun 2021
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Jaival Pharmaceuticals LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaival Pharmaceuticals LLP

Jaival Pharmaceuticals is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 21 April 2021 (5+ years old) and is registered under LLPIN AAW-7813.

Jaival Pharmaceuticals has 2 current designated partners:

The GSTIN of Jaival Pharmaceuticals is 27AARFJ1523C1ZK, registered in Maharashtra.

The LLPIN (Limited Liability Partnership Identification Number) of Jaival Pharmaceuticals is AAW-7813. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Jaival Pharmaceuticals was incorporated on 21 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.

Ekta Yogeshkumar Gulati was appointed as Designated Partner on 21 Apr 2021. Jay Babu Athawale was appointed as Designated Partner on 21 Apr 2021.

Yes, Jaival Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Jaival Pharmaceuticals is at 487 Narayan Nagar Vacal Stock Yard Depot Ghatkopar West, Mumbai, Maharashtra, India – 400086.

The total obligation of contribution is ₹1.5 Lakh.

Jaival Pharmaceuticals operates in the chemicals industry, in the chemicals and chemical products segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available